drugset / Trial / NCT01302171
Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Phase 2
Completed
60 enrolled
Barts & The London NHS Trust
Royal Brompton & Harefield NHS Foundation Trust · collabUniversity College London Hospitals · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomised, double-blind, placebo-controlled trial to evaluate the role of intracoronary injection of progenitor cells compared to placebo injection in patients with Dilated Cardiomyopathy who have been pre-treated with G-CSF (Granocyte™) injections for 5 days, and patients treated with a 5 day course of G-CSF (Granocyte™) injection only compared to placebo injection
Timeline
- Start
- 2010-08
- Primary completion
- 2012-12
- Completion
- 2013-07
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenograstim | Protein / enzyme biologic | 10 ug/kg | Subcutaneous |